1 / 34

Accommodation in ABO-Incompatible Kidney Allografts: Graft Self-Protection via Downregulation of Genes

Accommodation in ABO-Incompatible Kidney Allografts: Graft Self-Protection via Downregulation of Genes Joseph P. Grande, M.D., Ph.D. Mark D. Stegall, M.D. Walter D. Park Mayo Clinic - Rochester, MN USA METHODS 16 ABO-incompatible allografts studied at 3 and 12 months RESULTS

andrew
Download Presentation

Accommodation in ABO-Incompatible Kidney Allografts: Graft Self-Protection via Downregulation of Genes

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Accommodation in ABO-Incompatible Kidney Allografts: Graft Self-Protection via Downregulation of Genes Joseph P. Grande, M.D., Ph.D. Mark D. Stegall, M.D. Walter D. Park Mayo Clinic - Rochester, MN USA

  2. METHODS • 16 ABO-incompatible allografts studied at 3 and 12 months

  3. RESULTS • Circulating anti-blood group antibody and target blood group antigen demonstrated in all patients • 13/16 grafts had normal renal function and histology • 3 grafts with prior humoral rejection demonstrated significant glomerulopathy

  4. METHODS • Compared five one-year protocol ABO-compatible biopsies to four accommodated ABO-incompatible graft biopsies • Alterations in gene expression in 440 probe sets identified • Smads • Protein tyrosine kinase • TNFa • Mucin 1 • Alterations in gene expression verified by RT-PCR and/or immunohistochemistry

  5. RESULTS • Genes not increased in ABO-incompatible grafts • Heme oxygenase 1 • Bcl-2 • Bcl-XL

  6. CONCLUSIONS • Accommodation is present in well-functioning ABO-incompatible renal allografts • Accommodation may involve several novel mechanisms including perturbation of signal transduction, alterations in cellular adhesion, and prevention of apoptosis

  7. INTRODUCTION • ABO-incompatible allografts have been used to meet donor shortage • Refinements in immunosuppression and patient selection have increased survival of ABO-incompatible renal allografts • Anti-donor blood group antibody usually returns and persists despite chronic immunosuppression

  8. INTRODUCTION • In most patients, the graft continues to function well despite the presence of antibody • Mechanisms underlying “accommodation” are unclear

  9. METHODS • 16 ABO-incompatible living donor renal allografts performed between May 1999-January 2001 • Immunosuppression • Thymoglobulin antibody induction (1.5 mg/kg/dx 10 d) • Tacrolimus (target 15 ng/dl) • Mycophenolate mofetil (2 g/d) • Prednisone (500 mg taper to 10 mg/d by 3 months)

  10. METHODS • Recipients of non-A2 kidneys received pre-transplant plasmaphoresis (daily x4) and splenectomy at time of transplant • Controls consisting of 5 ABO-compatible patients, with normal three-month and one year protocol biopsies and stable function

  11. METHODS • Antibody titers • A1 or B blood group red cells suspended in dilutions of recipient serum • Immediate spin assay represents IgM activity • Specimens incubated at 37° and with anti-human globulin represents IgG activity

  12. METHODS • Accommodation, definition • Detectible antidonor antibody in recipient serum • Normal histology by light microscopy • Persistence of A or B antigen in the kidney • GFR >45 mL/min/1.73 m2

  13. MICROARRAY ANALYSIS • 16 gauge biopsies placed in RNA later (Ambien, Inc.) • RNA extracted with TRIzol reagent (Invitrogen) core • RNA purified using RNeasy Mini Kit (Qiagen, Inc.)

  14. MICROARRAY ANALYSIS • Sample quality assessed with Agilent 2100 Bioanalyzer for 18 and 28 s at RNA peaks • Biotinylated target RNA prepared from total RNA and hybridization of cRNA to Affymetrix test 3 and U95Av2 microarrays performed in microarray core facility

  15. STATISTICAL ANALYSIS • Log average ratio calculated by gene shift microarray suite v4.01 (Affymetrix) • Hybridization index: average LAR for a transcript within a group of samples D HI = HIaccommodation – HIABO compatible • Gene expression verified by RT-PCR

  16. RESULTS • Patient and graft survival 100% at one year • No hyperacute or acute cellular rejection identified • Four patients had episode of humor rejection in first month after transplant • Responded to corticosteroids and plasmapheresis

  17. RESULTS • All 16 patients showed persistence of donor blood group antigen in the graft and anti-blood group antibody in circulation • 13 patients had normal renal function and normal kidney biopsy • 7 recipients of A2 kidneys • 6 recipients of non-A2 kidneys who had undergone splenectomy

  18. RESULTS • Anti-donor blood group antibody levels lower than pre-transplant levels • Accommodated group had less IgM at 3 and 12 months than pre-transplant levels

  19. RESULTS • Of 12,600 genes examined by U95Av2 • 4933 had HI values <1 or exhibited small changes in expression • 440 probe sets had significant changes in expression • 404 downregulated • 33 upregulated

  20. RESULTS • Upregulated genes • Protein tyrosine kinase GFRA1 • Immunoregulator MUC1 • Downregulated genes • TNF • Smad5

  21. RESULTS • Unable to detect • HO-1 • Bcl-2 • Bcl-XL • Bax • MUC1 expression strongly positive along glomerular capillary wall

  22. RESULTS • Accommodation can occur over a wide range of anti-blood group antibody titers • 6 of 13 patients with anti-A/B anti-titers >1:32 had excellent graft function at one year • Protocol biopsies of these patients were unremarkable.

  23. MECHANISMS OF GRAFT INJURY • Complement-mediated vascular thrombosis • Antibody-dependent cellular cytotoxicity • Binding of antibody to endothelial cell antigen • Endothelial cell apoptosis

  24. ACCOMMODATION • Recent studies suggest that some forms of accommodation are associated with induction of anti-apoptotic genes • HO-1 • Bcl-XL

  25. RESULTS • TGF- signaling is reduced in accommodated grafts • Smad4 D HI -1.06, P = 0.022 • Smad5 D HI -1.68, P = 0.014 • EGFR D HI +0.63, P = 0.010

  26. RESULTS • Protein tyrosine kinases • GFRA1 D HI +1.45, P = 0.018 • Receptor which mediates binding and activation of RET • PRKB D HI -2.04, P = 0.003 • PRKB binds cAMP

  27. TNF FAMILY • TNF D HI -0.82, P = 0.033 • TACE D HI +1.16, P = 0.044 • Cleaves precursor TNF to its mature form • TRAF6 D HI -0.97, P = 0.030

  28. TNF FAMILY • MUC1 D HI 1.18, P = 0.016 • Transmembrane protein expressed on the apical surface of ductal epithelial cells • Involved in • Cell adhesion • Cell signaling • Immunoregulation

  29. LIMITATIONS, MICROARRAY ANALYSIS • Decreased sensitivity of microarrays • Heterogeneous cell populations • Reproducibility

  30. SUMMARY • Accommodation is associated with alterations in genes related to • Signal transduction • Cell-cell adhesion • T-cell activation • Prevention of apoptosis (pro-survival pathways)

More Related